• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑血容量和对比剂转移系数能否预测人类胶质瘤的预后?

Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?

作者信息

Mills S J, Patankar T A, Haroon H A, Balériaux D, Swindell R, Jackson A

机构信息

Department of Imaging Science and Biomedical Engineering, Christie Hospital NHS Trust, Manchester, United Kingdom.

出版信息

AJNR Am J Neuroradiol. 2006 Apr;27(4):853-8.

PMID:16611778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8133992/
Abstract

INTRODUCTION

Noninvasive measurements of cerebral blood volume (CBV) and contrast transfer coefficient (K(trans)) have potential benefits in the diagnosis and therapeutic management of adult glioma. This study examines the relationship between CBV, K(trans), and overall survival.

METHODS AND MATERIALS

Twenty-seven adult patients with glioma underwent T1-weighted dynamic contrast-enhanced MR imaging, and parametric maps of CBV and K(trans) were calculated. The relationship of histologic grade, CBV, K(trans), age, sex, surgical resection, and use of adjuvant therapy to survival were analyzed by using the logrank method and Cox regression analysis. The Kaplan-Meier method for displaying survival curves was used. The relationship of factors such as comorbidity, elevated intracranial pressure, size of nonenhancing tumor, and peritumoral edema were not considered.

RESULTS

Both CBV (P < .01) and K(trans) (P < .01) show a significant relationship to histologic grade. CBV (P = .004), K(trans) (P = .008), and histologic grade (P < .001) all demonstrate a significant association with patient survival when analyzed individually. Cox regression analysis identified only histologic grade (P < .01) and K(trans) (P < .05) as independent significant prognostic indicators. Examination of survival data from high-grade (III and IV) tumors demonstrated a linear relationship between K(trans) and patient survival (P < .01).

CONCLUSION

This study suggests a direct relationship between K(trans) and length of survival in high-grade gliomas, which could be of clinical importance. CBV relates directly to histologic grade but provides no independent prognostic information over and above that provided by grade. Further large prospective studies should be planned to test whether this observation holds true.

摘要

引言

脑血容量(CBV)和对比剂转移系数(K(trans))的无创测量在成人胶质瘤的诊断和治疗管理中具有潜在益处。本研究探讨了CBV、K(trans)与总生存期之间的关系。

方法与材料

27例成年胶质瘤患者接受了T1加权动态对比增强磁共振成像,并计算了CBV和K(trans)的参数图。采用对数秩检验法和Cox回归分析,分析组织学分级、CBV、K(trans)、年龄、性别、手术切除及辅助治疗的使用与生存期的关系。采用Kaplan-Meier法绘制生存曲线。未考虑合并症、颅内压升高、无强化肿瘤大小及瘤周水肿等因素的关系。

结果

CBV(P <.01)和K(trans)(P <.01)均与组织学分级显著相关。单独分析时,CBV(P =.004)、K(trans)(P =.008)和组织学分级(P <.001)均与患者生存期显著相关。Cox回归分析仅确定组织学分级(P <.01)和K(trans)(P <.05)为独立的显著预后指标。对高级别(III级和IV级)肿瘤的生存数据进行分析,结果显示K(trans)与患者生存期呈线性关系(P <.01)。

结论

本研究表明,高级别胶质瘤中K(trans)与生存期长短直接相关,这可能具有临床重要性。CBV与组织学分级直接相关,但除分级所提供的信息外,未提供独立的预后信息。应计划进一步开展大型前瞻性研究,以验证这一观察结果是否成立。

相似文献

1
Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?脑血容量和对比剂转移系数能否预测人类胶质瘤的预后?
AJNR Am J Neuroradiol. 2006 Apr;27(4):853-8.
2
Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.使用动态磁敏感对比增强灌注磁共振成像,比较从单室获得的灌注指标与药代动力学建模方法在不同胶质瘤分级中的应用。
AJNR Am J Neuroradiol. 2006 Oct;27(9):1975-82.
3
Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?体积转移系数(K(trans))与人类胶质瘤的组织学分级有关吗?
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2455-65.
4
Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.胶质瘤患者肿瘤免疫组织化学与动态对比增强及DSC-MRI参数的相关性
AJNR Am J Neuroradiol. 2016 Dec;37(12):2217-2223. doi: 10.3174/ajnr.A4908. Epub 2016 Sep 1.
5
Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.动态对比增强和动态磁敏感对比灌注磁共振成像用于胶质瘤分级:使用热点和直方图分析对血管腔室和通透性参数的初步比较
Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22.
6
Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.高级别胶质瘤中动态对比增强磁共振成像和动态磁敏感对比增强磁共振成像的体素转移常数与脑血容量估计值的逐像素比较
AJNR Am J Neuroradiol. 2015 May;36(5):871-6. doi: 10.3174/ajnr.A4231. Epub 2015 Jan 29.
7
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.胶质瘤:在动态磁敏感加权对比增强灌注磁共振成像中通过脑血容量测量预测进展时间或生存期
Radiology. 2008 May;247(2):490-8. doi: 10.1148/radiol.2472070898. Epub 2008 Mar 18.
8
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.通过动态磁敏感对比增强灌注磁共振成像比较脑血容量和血管通透性与胶质瘤分级的关系。
AJNR Am J Neuroradiol. 2004 May;25(5):746-55.
9
Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma.肿瘤灌注参数的治疗后变化有助于预测高级别星形细胞瘤患者的生存期。
Eur Radiol. 2017 Aug;27(8):3392-3400. doi: 10.1007/s00330-016-4699-2. Epub 2016 Dec 20.
10
Preoperative prognostic value of dynamic contrast-enhanced MRI-derived contrast transfer coefficient and plasma volume in patients with cerebral gliomas.动态对比增强磁共振成像衍生的对比剂转移系数和血容量在脑胶质瘤患者中的术前预后价值
AJNR Am J Neuroradiol. 2015 Jan;36(1):63-9. doi: 10.3174/ajnr.A4006. Epub 2014 Jun 19.

引用本文的文献

1
Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma.影像学在高级别胶质瘤的诊断、预后及治疗反应预测中的作用
J Med Signals Sens. 2024 Mar 27;14:7. doi: 10.4103/jmss.jmss_30_22. eCollection 2024.
2
PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.PDZK1与高级别胶质瘤的动态对比增强磁共振成像(DCE-MRI)灌注参数相关。
Clinics (Sao Paulo). 2024 Apr 30;79:100367. doi: 10.1016/j.clinsp.2024.100367. eCollection 2024.
3
Perfusion MR prior to radiotherapy is a strong predictor of survival in high-grade gliomas after proton and carbon ion radiotherapy.放疗前的灌注磁共振成像(Perfusion MR)是高级别胶质瘤在质子和碳离子放疗后生存的有力预测指标。
Ann Transl Med. 2022 Nov;10(22):1199. doi: 10.21037/atm-20-1646.
4
Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.脑弥漫性胶质瘤的血流动力学成像——A部分:概念、鉴别诊断及肿瘤分级
Cancers (Basel). 2022 Mar 10;14(6):1432. doi: 10.3390/cancers14061432.
5
Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions.脑弥漫性胶质瘤的血流动力学成像 - 第二部分:分子关联、治疗效果监测、预后及未来方向
Cancers (Basel). 2022 Mar 5;14(5):1342. doi: 10.3390/cancers14051342.
6
Advancements in Neuroimaging to Unravel Biological and Molecular Features of Brain Tumors.神经成像技术的进展以揭示脑肿瘤的生物学和分子特征
Cancers (Basel). 2021 Jan 23;13(3):424. doi: 10.3390/cancers13030424.
7
Evaluating survival in subjects with astrocytic brain tumors by dynamic susceptibility-weighted perfusion MR imaging.应用动态磁敏感对比灌注磁共振成像评估星形细胞瘤患者的生存情况。
PLoS One. 2021 Jan 6;16(1):e0244275. doi: 10.1371/journal.pone.0244275. eCollection 2021.
8
Comparison of Dynamic Contrast-Enhancement Parameters between Gadobutrol and Gadoterate Meglumine in Posttreatment Glioma: A Prospective Intraindividual Study.钆布醇与钆特醇在治疗后脑胶质瘤的动态对比增强参数比较:一项前瞻性个体内研究。
AJNR Am J Neuroradiol. 2020 Nov;41(11):2041-2048. doi: 10.3174/ajnr.A6792. Epub 2020 Oct 15.
9
Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II-III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI.术前基于弥散加权成像简化灌注分数对 IDH1 突变型 WHO Ⅱ-Ⅲ级脑胶质瘤的预测:与动态对比增强和体素内不相干运动 MRI 的比较。
Radiol Oncol. 2020 Jun 19;54(3):301-310. doi: 10.2478/raon-2020-0037.
10
Macrovascular Networks on Contrast-Enhanced Magnetic Resonance Imaging Improves Survival Prediction in Newly Diagnosed Glioblastoma.对比增强磁共振成像上的大血管网络改善新诊断胶质母细胞瘤的生存预测
Cancers (Basel). 2019 Jan 14;11(1):84. doi: 10.3390/cancers11010084.

本文引用的文献

1
Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?体积转移系数(K(trans))与人类胶质瘤的组织学分级有关吗?
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2455-65.
2
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.通过动态磁敏感对比增强灌注磁共振成像比较脑血容量和血管通透性与胶质瘤分级的关系。
AJNR Am J Neuroradiol. 2004 May;25(5):746-55.
3
Measuring blood volume and vascular transfer constant from dynamic, T(2)*-weighted contrast-enhanced MRI.通过动态T(2)*加权对比增强磁共振成像测量血容量和血管转运常数。
Magn Reson Med. 2004 May;51(5):961-8. doi: 10.1002/mrm.20049.
4
A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas.传统药代动力学模型与首过药代动力学模型在人类胶质瘤中获得的Ktrans测量值的比较。
J Magn Reson Imaging. 2004 May;19(5):527-36. doi: 10.1002/jmri.20045.
5
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].与传统对比增强磁共振成像相比,利用动态自旋回波磁共振磁化率成像进行胶质肿瘤分级及预后预测:少突胶质细胞瘤相对脑血容量升高的混杂效应[校正后]
AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21.
6
New hybrid technique for accurate and reproducible quantitation of dynamic contrast-enhanced MRI data.用于动态对比增强MRI数据准确且可重复定量分析的新型混合技术。
Magn Reson Med. 2003 Dec;50(6):1286-95. doi: 10.1002/mrm.10652.
7
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.胶质瘤分级:与传统磁共振成像相比,灌注磁共振成像和质子磁共振波谱成像的敏感性、特异性及预测价值
AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98.
8
Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.脑肿瘤血流定量分析:动脉自旋标记与动态磁敏感加权对比增强磁共振成像的比较
Radiology. 2003 Aug;228(2):523-32. doi: 10.1148/radiol.2282020409. Epub 2003 Jun 20.
9
Dynamic susceptibility contrast MRI of gliomas.胶质瘤的动态磁敏感对比磁共振成像
Neuroimaging Clin N Am. 2002 Nov;12(4):501-23. doi: 10.1016/s1052-5149(02)00026-6.
10
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma.新诊断胶质瘤定量动态对比增强磁共振成像的可重复性
Br J Radiol. 2003 Mar;76(903):153-62. doi: 10.1259/bjr/70653746.